Esperion to Participate in Fireside Chat at March 2018 Investor Conferences
March 07, 2018 16:01 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., March 07, 2018 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective,...
Esperion Announces Positive Top-Line Results from First Pivotal Phase 3 Study of Bempedoic Acid
March 07, 2018 07:30 ET
|
Esperion Therapeutics, Inc.
— Study 4 Met Primary Endpoint with 28% Additional LDL-C Lowering on Background Ezetimibe and Up to the Lowest Daily Dose of a Statin — — hsCRP Reduction of 33% — — Observed to be Safe and...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 23, 2018 16:30 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective,...
Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Fourth Quarter and Full Year 2017 Financial Results
February 20, 2018 07:30 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective,...
Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference
January 03, 2018 16:30 ET
|
Esperion Therapeutics, Inc.
Fireside Chat Webcast on Wednesday, January 10, 2018 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time ANN ARBOR, Mich., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc....
Esperion Announces the Appointment of Jeffrey Berkowitz to Board of Directors
December 14, 2017 16:30 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 01, 2017 16:30 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...
Esperion to Participate in Fireside Chat at the Jefferies 2017 London Healthcare Conference
November 13, 2017 16:30 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...
Esperion to Participate in Fireside Chat at the Stifel 2017 Healthcare Conference
November 09, 2017 16:30 ET
|
Esperion Therapeutics, Inc.
Fireside Chat Webcast on Tuesday, November 14, 2017 at 8:45 a.m. Eastern Time ANN ARBOR, Mich., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management...
Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results
November 07, 2017 08:00 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...